Imprint
Ascenion GmbH Herzogstraße 64 80803 Munich Germany Phone +49 (0)89 318814-0 Fax +49 (0)89 318814-20 E-Mail info@ascenion.de Represented by: Dr. Christian A. Stein (CEO) Register Court: Amtsgericht München HRB 118236 VAT Identification Number: DE 812299325 Responsible for the content according to § 55 Abs. 2 RStV (see above)…
Knowledge and Technology Transfer for Academic Life-Science Research
Inventors
Protect, develop and commercialize ideas
Founders
Initiate and finance start-ups
Industry & Investors
Discover innovation opportunities
Our IP-Portfolio
Search over 700 technologies and research materials
Licensing, cooperation, investment
Your source of external innovation
You want to rejuvenate your pipeline or expand your portfolio? The chances are, we have exactly what you need: projects with a sound scientific basis and exceptional commercial potential. Our portfolio is as varied as our partners and currently comprises over 700 offers, each…
Training and advanced services
Promoting transfer culture and expertise
You want to strengthen awareness of knowledge and technology transfer and the associated expertise at your institute? We offer training courses for scientists and intensive workshops for your technology transfer team.
Our training courses and special services
…
Supporting founder teams
Getting start-ups going
You have a business idea and need a coach and sparring partner? We can support you with our accumulated experience from around 100 spin-off projects. We often work closely together with the scientists involved before the start-up is launched, helping with project development, financial and…
Ascenion at a glance
Download flyer
Certification
Since 2019, Ascenion is certified for its quality management in accordance with the European standard DIN EN ISO 9001:2015. The certification comprises the areas of consulting, evaluation and support for start-ups in life-science technology transfer, and also equity…
Benefiting research
Licensing revenues realized via agreements flow directly to the respective research institute. Would you like to learn more?
See 'Ascenion in figures'
Industry
Closely networked with decision makers and experts
Ascenion has built up an excellent network based on long-term personal contacts. It comprises a broad…
Classical CRISPR screens enable comprehensive gene function analyses in vitro. Their meaningfulness is nevertheless limited, as they do not fully re ject the complexity of living organisms. Reliable and reproducible in vivo screening often fails, because the effects of genetic changes are very weak due to insuf ficient representation of the…
The home ventilator ‘eva’ was approved mid-2024 under the EU’s new Medical Device Regulation (MDR), followed in November by its inclusion in the Technical Aids Register of medical devices reimbursed by the German health insurance companies. Demand for the ventilator is high: nearly 200 devices were sold by the end of the year alone.
‘We have…
The transition from inpatient to outpatient care can lead to an interruption in treatment, particularly in severe mental illness. Dr Jakob Kaminski, cofounder of Recovery Cat and psychiatrist and psychotherapist at the Charité – Universitätsmedizin Berlin has encountered this problem often.
Together with an interdisciplinary team, he has…
It began with frustration over in flexible hospital information systems (HIS): time spent on documentation in hospitals is growing, and yet crucial information required for optimal treatment is often missing. Andrea Kreichgauer and Jasper Mecklenburg, founders of dotbase, experienced this themselves at the Charité – Universitätsmedizin…
Proteomics holds great promise for biomedical research – from understanding disease mechanisms to discovering new biomarkers. Over the past decade, advances in mass spectrometry and software have signi ficantly expanded what’s possible, but the field has yet to fully take off – largely because data analysis remains complex and…
For decades, genomic diagnostics focused on just 2% of our DNA – the protein-coding part – leaving the vast ‘dark genome’ largely uncharted. Now, Lucid Genomics, a spin-off from the Max Planck Institute for Molecular Genetics and Charité – Universitätsmedizin Berlin, is revealing its diagnostic potential.
Founded by Uirá Souto Melo and…
Your contact persons at Hannover Medical School
Dr Ralf Cordes Dr Sören Rindfleisch Dr Torben Söker
Office Hannover directly at the MHH: building M19 2nd floor, room 1660 Helstorfer Straße 7, 30625 Hannover T: +49 511 532-8921 <link hannover@ascenion.de - mail>hannover@ascenion.de</link>
Start your company
Startup Pitch & Partner
Start-ups
Getting start-ups off the ground
Supporting start-ups is a particular focus of our work. We have already accompanied over 100 start-up projects. You too can benefit from our experience!
As a company founder: Together, we create favourable starting conditions, avoiding the mistakes that…
At the fifth portfolio conference of the Institute for Biomedical Translation (IBT) Lower Saxony at the TRAFO Hub in Brunswick, the two projects were named winners after competing against five other teams from research institutes in Lower Saxony. The first phase of funding will focus on rapid scientific and market-oriented development with the aim…
